Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
126.00    -1.60 (-1.25%)
Bid:
125.20
Ask:
126.00
Spread: 0.80 (0.639%)
Market Cap: £524.68m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre-Close Trading Update

23 Jul 2010 07:00

RNS Number : 7995P
James Halstead PLC
23 July 2010
 



23 July 2010

 

 

James Halstead plc ("James Halstead" or the "Company")

 

Pre-Close Trading Update

 

Following the year-end, and prior to the announcement of our full trading results in late September, James Halstead issues the following trading update. In summary, James Halstead expects to achieve market expectations for another record year for profits.

 

As anticipated by the Chairman in the interim results announcement of 31 March 2010, overseas sales have matched or exceeded expectations with increased global demand and the assistance of favourable exchange rates. We have increased sales in most markets despite the difficult economic conditions. Europe has seen strong growth, as well as North America, the Middle East and Asia.

 

Maritime and transport sectors have been particularly buoyant and Polyflor continues to perform strongly, having won new contracts to supply Gorki Automotive (Russia) and a number of ship building projects in Turkey, Korea and Asia.

 

Polyflor ROF, a specialist safety product, originally designed for the Royal Ordnance factories, is being specified by many governments which has resulted in a number of notable projects in the last few months.

 

As also anticipated in the interim statement, UK revenue is broadly in line with last year. The company is trading well although many UK infrastructure spending plans have been deferred or delayed. In our home market we are benefiting from customers moving to the longer lasting, and cheaper types of resilient flooring that are our speciality. We continue to see growth in transport and refurbishment spending.

 

Although we are pleased with the progress made in sales growth, we are experiencing raw material prices ahead of our expectations, particularly for plasticisers and polymers and in some cases there have been restrictions in availability. Whilst the situation is currently manageable, it is not ideal and may continue for several months. Overall, we have started our new financial year confidently despite the global recessionary backdrop, and we continue to focus on the further growth of our business in the coming year.

-ends-

Enquiries:

 

James Halstead

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

 

0161 767 2500

Hudson Sandler

Nick Lyon / Michael Sandler

 

020 7796 4133

Altium

Ben Thorne / Paul Chamberlain

020 7484 4040

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKBDDABKDCOB
Date   Source Headline
9th Apr 20265:32 pmRNSGrant of Options
8th Apr 20265:19 pmRNSHolding(s) in Company
31st Mar 20267:00 amRNSInterim Results
23rd Feb 20264:48 pmRNSPDMR Acquisition of Shares
30th Jan 20263:32 pmRNSShare Buyback - Replacement
30th Jan 20262:44 pmRNSShare Buyback
29th Jan 20267:00 amRNSTrading Update
8th Jan 20268:20 amRNSBlock Listing Six Monthly Return
5th Dec 20251:00 pmRNSResult of AGM
5th Dec 20257:00 amRNSChairman’s Statement to the Annual General Meeting
14th Nov 202512:12 pmRNSDirector/PDMR Shareholding
14th Nov 202512:11 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSPosting of Annual Report and Notice of AGM
1st Oct 20257:00 amRNSPreliminary Results
8th Sep 20257:00 amRNSNotice of Preliminary Results
29th Aug 20253:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSTrading Update
9th Apr 20255:32 pmRNSHolding(s) in Company
7th Apr 202512:25 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSInterim Results
6th Mar 202510:41 amRNSNotice of Interim Results - Replacement
6th Mar 20259:00 amRNSNotice of Inteirm Results
6th Mar 20257:00 amRNSNotice of Interim Results
31st Jan 20257:00 amRNSTrading Update and Notice of Results
27th Jan 20255:09 pmRNSDirector/PDMR Shareholding
6th Jan 20253:15 pmRNSBlock Listing Six Monthly Return
6th Dec 20242:09 pmRNSResults of AGM
6th Dec 20247:00 amRNSAGM Statement
18th Oct 20249:20 amRNSPosting of Annual R&A and Notice of AGM
1st Oct 20247:00 amRNSBoard Changes
1st Oct 20247:00 amRNSPreliminary Results
7th Aug 20248:05 amRNSBlock Listing Six Monthly Return
31st Jul 20247:00 amRNSTrading Update
15th Jul 20247:00 amRNSChange of Broker
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.